We performed a sensitivity analysis, cumulating all randomized clinical trials (RCTs) in which patients with metastatic castration-resistant prostate cancer (mCRPC) received systemic therapy, to evaluate if the comparison of RCTs may drive to biased survival estimations. An overall survival (OS) ...
Use of five-year survival statistics is more useful in aggressive diseases that have a shorter life expectancy following diagnosis, such as lung cancer, and less useful in cases with a long life expectancy, such as prostate cancer. 五年存活率統計的使用,在診斷後存活期較短的疾病非常有用(如肺癌...
Telemedicine Market Size and Forecast:The globaltelemedicine marketsize was valued at USD 60.8 billion in 2022 and it is expected to reach USD 225 billion by 2030, growing with a compound annual growth rate (CAGR) of 17.16% during the forecast period 2022 to...
These illnesses are estimated to cause 57,380 facilities, accounting for 9.4% of all cancer deaths. The 5-year relative survival rate for leukemia has doubled, with 437,337 patients now in remission. Hodgkin and non-Hodgkin lymphoma have also incr...
"For patients with prostate cancer, we have a nearly 100 percent five-year survival rate, and breast cancer has made tremendous strides as well, with five-year survival rising from 75 percent in 1975 to almost 89 percent in 2012," said Rowland. "However, we clearly need to have better di...